These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 3572788)

  • 1. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.
    Bowyer JF; Masserano JM; Weiner N
    J Pharmacol Exp Ther; 1987 Jan; 240(1):177-86. PubMed ID: 3100768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1989 Feb; 248(2):514-20. PubMed ID: 2465405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-2 adrenergic inhibition of Ca(++)-evoked [3H]norepinephrine release from synaptosomes is blocked by depolarization.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1063-9. PubMed ID: 1972747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
    Taglialatela M; Amoroso S; Kaparos G; Maurano F; Di Renzo GF; Annunziato L
    J Pharmacol Exp Ther; 1988 Aug; 246(2):682-8. PubMed ID: 2457079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
    Maura G; Giardi A; Raiteri M
    J Pharmacol Exp Ther; 1988 Nov; 247(2):680-4. PubMed ID: 2903237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic modulation of evoked [3H]D-aspartate release by D-2 dopamine receptors in rat striatal slices.
    Peris J; Dwoskin LP; Zahniser NR
    Synapse; 1988; 2(4):450-6. PubMed ID: 2973144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter mediated release of dopamine: role of chloride.
    Sitges M; Reyes A; Chiu LM
    J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
    Taglialatela M; Amoroso S; Canzoniero LM; Di Renzo GF; Annunziato L
    J Pharmacol Exp Ther; 1988 Aug; 246(2):689-94. PubMed ID: 2841453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2(+)-evoked [3H]dopamine release from synaptosomes is dependent on neuronal type Ca2+ channels and is not mediated by acetylcholine, glutamate or aspartate release.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1990 Aug; 254(2):664-70. PubMed ID: 1974645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
    Dwoskin LP; Teng L; Buxton ST; Crooks PA
    J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na(+)-Ca2+ exchange activity in central nerve endings. II. Relationship between pharmacological blockade by amiloride analogues and dopamine release from tuberoinfundibular hypothalamic neurons.
    Taglialatela M; Canzoniero LM; Cragoe EJ; Di Renzo G; Annunziato L
    Mol Pharmacol; 1990 Sep; 38(3):393-400. PubMed ID: 2402228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
    L'hirondel M; Chéramy A; Godeheu G; Artaud F; Saiardi A; Borrelli E; Glowinski J
    Brain Res; 1998 May; 792(2):253-62. PubMed ID: 9593923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    Dwoskin LP; Zahniser NR
    J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release.
    Maura G; Carbone R; Raiteri M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1142-6. PubMed ID: 2574740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of verapamil on the release of different neurotransmitters.
    Sitges M; Reyes A
    J Neurosci Res; 1995 Apr; 40(5):613-21. PubMed ID: 7602614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.
    Giorguieff MF; Le Floc'h ML; Glowinski J; Besson MJ
    J Pharmacol Exp Ther; 1977 Mar; 200(3):535-44. PubMed ID: 850127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.